GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Research & Development

Magle Chemoswed Holding AB (OSTO:MAGLE) Research & Development : kr0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Magle Chemoswed Holding AB's Research & Development for the three months ended in Mar. 2024 was kr0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.0 Mil.

Magle Chemoswed Holding AB Research & Development Historical Data

The historical data trend for Magle Chemoswed Holding AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB Research & Development Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Magle Chemoswed Holding AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magle Chemoswed Holding AB  (OSTO:MAGLE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Magle Chemoswed Holding AB Research & Development Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Research & Development
Comparable Companies
OSTO:ACOU OSTO:CLBIO OSTO:KAN OSTO:ATORX OSTO:GUARD OSTO:SANION OSTO:BIOWKS OSTO:ABLI OSTO:IMMU OSTO:IRLAB A OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Website
https://www.maglechemoswed.com
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines